defense · stock-purchase · committee-conflict
Sen. John Boozman Buys Into Palantir Just Before a 16% Slide
The senior appropriator’s first-time purchase of the defense contractor occurred alongside heavy corporate insider selling.
2026-06-28 — John Boozman · PLTR
Key facts
- Sen. John Boozman purchased between $1,001 and $15,000 of Palantir Technologies (PLTR) stock on May 15, 2026.
- Since the purchase, PLTR shares have declined by approximately 15.7%.
- Boozman serves on the Senate Appropriations Committee, which has direct oversight of federal discretionary budgets for defense and intelligence contracting.
- The purchase coincided with net insider selling at Palantir, including same-day sales by director Alexander D. Moore.
Sen. John Boozman (R-Ark.) recently dipped his toes into the enterprise software market, only to watch his new investment quickly lose ground.
According to financial disclosures, Boozman purchased between $1,001 and $15,000 of Palantir Technologies Inc. (PLTR) stock on May 15, 2026. Since the transaction, shares of the defense and intelligence software contractor have fallen approximately 15.7%.
The trade represents Boozman's first-time purchase of Palantir. As a member of the powerful Senate Appropriations Committee, which holds broad authority over federal agency budgets and discretionary spending, Boozman helps oversee the purse strings that fund major government software contractors. He also serves as the chair of the Senate Committee on Agriculture, Nutrition, and Forestry, though that panel has no direct connection to national security software.
Under the STOCK Act, members of Congress are required to disclose their financial transactions within 45 days of the trade date, and the values are reported in broad ranges rather than exact amounts. Boozman disclosed his Palantir transaction on June 16, 2026, 32 days after the trade.
Our analysis scored the transaction a 28 out of 100, reflecting its small size and the lack of clear non-public catalysts. The purchase came 11 days after Palantir filed its Q1 2026 earnings report, which showed strong revenue growth and raised full-year guidance. This delay suggests the senator’s trade may have been a retail-style reaction to highly public, positive financial news.
However, corporate insiders at Palantir were moving in the opposite direction. On the exact day of Boozman's purchase, Palantir director Alexander D. Moore executed multiple open-market sales. Less than a week later, on May 20, several of the company's top executives—including CEO Alex Karp and President Shyam Sankar—also filed disclosures for heavy open-market sales.
The trade was not an isolated event for Boozman's portfolio. On the same day, he executed an identical purchase of specialty chemicals company Albemarle Corp. (ALB) in the $1,001-to-$15,000 range. The paired trades suggest a routine, small-scale portfolio rebalancing or professional management executing a minor thematic reallocation.
Buying the dip is hard; buying right before the dip is harder.
Sources
- Palantir Q1 2026 earnings 8-K — SEC EDGAR
- Palantir SEC Form 4 filings — SEC EDGAR